Cellectar Biosciences, Inc. - Common Shares (CLRB) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / Common Shares
Symbol
CLRB on Nasdaq
Shares outstanding
3,289,474
Price per share
$4.02
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
296,154
Total reported value
$1,650,372
% of total 13F portfolios
0%
Share change
+192,757
Value change
+$1,061,107
Number of holders
21
Price from insider filings
$4.02
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectar Biosciences, Inc. - Common Shares (CLRB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Bleichroeder LP 6.1% $1,120,000 200,000 Bleichroeder LP 30 Sep 2025
Hexstone Capital LLC 5.6% 150,000 Hexstone Capital LLC 02 Jul 2025
INTRACOASTAL CAPITAL, LLC 5% 140,101 Mitchell P. Kopin 01 Jul 2025
LYTTON LAURENCE W 1.6% $247,705 51,391 LYTTON LAURENCE W 30 Jun 2025
Nantahala Capital Management, LLC 0.06% $5,345 1,109 Nantahala Capital Management, LLC 30 Jun 2025

As of 30 Sep 2025, 21 institutional investors reported holding 296,154 shares of Cellectar Biosciences, Inc. - Common Shares (CLRB). This represents 9% of the company’s total 3,289,474 outstanding shares.

Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 296,154 $1,650,372 +$1,061,107 $5.60 21
2025 Q2 103,397 $734,048 +$734,048 $7.11 19